AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Sep 9, 2005
35134_dirs_2005-09-09_7cc7b8ad-4b9f-45ac-9b69-6b369efc0b80.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2005-09-09
Reporting Person: MANDEL RICHARD H JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-09-09 | Croff Preferred B Shares | S | 7702 | $3 | Acquired | 8000 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16